The market for genomics was valued at US$ 25 billion in 2021 and is anticipated to grow at a CAGR of 16% from 2023 to 2032.
Genomics is the investigation of the entirety of an individual's qualities (the genome), including connections of those qualities with one another and with the individual's current circumstance. Your genome contains numerous significant pieces of information about you—from your heritage to the way your body reacts to illnesses, drugs, and maturing. The quickly arising field of genomics is changing our comprehension of human wellbeing and empowering progresses that advantage the entirety of humanity.
Investigation of qualities at the utilitarian level is one of the primary employments of genomics, a region referred to by and large as practical genomics. The expanding execution of positive government drives, falling expenses of sequencing services, and mushrooming necessity for customized medication are the preeminent points driving the global genomics market.
Combined with expanding selection of new sequencing advancements, it will set out development open doors for the market around here. Rising inclination for customized drugs is another factor lending a helping hand for the rise of market.
In recent years clinics and centers are moving from customary genomic testing techniques to practical and more touchy strategies, for example, whole-exome sequencing, which is a factor driving the market development. For as long as a couple of years, direct-to-customer genomic tests are being offered by organizations, bringing about the changing of plans of action.
The principal factor driving the development of this market incorporate the expanding government subsidizing to help genomics projects, the developing occurrence of malignancy and expanding utilization of NGS in disease research, the section of new players and new companies in the genomics market, and the developing application spaces of genomics.
Global Genomics Market Value Share Analysis, by Geography (2022)
The report titled “Global Genomics market - Global market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global genomics market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global genomics market is segmented on the basis of Product type, Application type, Technology type, and geography. Based on product type, the global genomics market is segmented into Systems & Software, Consumables, Services. Based on Application type, the global genomics market is segmented into Sequencing, Microarray, PCR. Based on Technology type, the global genomics market is segmented into Diagnostic Application, Precision Medicine. Based on geography, the global genomics market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Italy, France, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, UAE, South Africa and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on global genomics market. Further, market share of prominent companies in the global genomics market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Genomics companies. The global genomics market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
Product portfolio would focus on all the products under the Genomics business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global genomics market.
The key players of the global genomics market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche (Switzerland), BGI (China), Eurofins Scientific (Germany), Oxford Nanopore Technologies (UK), Danaher Corporation (US), Merck KGaA (Germany), Eppendorf AG (Germany), Promega Corporation (US), Creative Biogene (US), New England Biolabs (US), Source BioScience (UK), Bionano Genomics (US), Macrogen, Inc. (South Korea), BioDiscovery (UK), Veritas Genetics International (US), and start-up companies such as 23andMe (US), Personalis (US), Novogene Co., Ltd. (China), Helix OpCo, LLC (US), Personal Genome Diagnostics Inc. (US), Phalanx Biotech Group (US), MedGenome (US), Resilient Biotics, Inc. (US), TruGenomix Health (US), and Cradle Genomics (US).
Global genomics market is segmented as
By Product and Service
By Technology
By Application
By Region
The expanding execution of positive government drives, falling expenses of sequencing services, and mushrooming necessity for customized medication are the preeminent points driving the global genomics market
Based on technology type, the genomics market is segmented into Diagnostic Application and Precision Medicine.
The sample report for the genomics Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.
The genomics market was valued at US$ 25 billion in 2021.
This market is dominated by the North American region.
The genomics market is estimated to exhibit a CAGR of 16% between 2023 to 2032.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved